In a 232-to-193 vote yesterday, the House passed a bill that would cap out-of-pocket insulin costs at $35 per month. Source: Drug Industry Daily

AbbVie’s Allergan subsidiary and Teva Pharmaceuticals have agreed to pay nearly $330 million to settle claims that they played a role in the opioid abuse and overdose crisis in Florida.…

The FDA included detailed recommendations for booster shot studies in a final guidance on Emergency Use Authorizations (EUAs) for COVID-19 vaccines released yesterday. Source: Drug Industry Daily

Clovis Oncology’s Rubraca (Rucaparib) nearly halved the risk of disease progression in women with newly diagnosed advanced ovarian cancer following treatment combined with platinum-based chemotherapy. Source: Drug Industry Daily

Akebia Therapeutics will have to conduct a new clinical trial if it wants to move its kidney disease drug vadadustat forward, the FDA said in a Complete Response Letter (CRL)…

The Department of Justice (DOJ) is reportedly investigating a large prescription drug-trafficking network that allegedly has and is selling hundreds of millions of dollars of counterfeit HIV medications. Source: Drug…

The FDA has accused a Polish company that manufactures and sells over-the-counter (OTC) products online of making a homeopathic drug cream that contains 100 million times the active concentration that…

In the final quarter of 2021, makers of brand-name pharmaceuticals increased their drugs’ wholesale acquisition cost, or WAC, by 4.4 percent, up from 3.8 percent during the same period in…

Roche has said its investigational monoclonal antibody, tiragolumab, combined with Tecentriq (atezolizumab) and chemotherapy did not meet the endpoints of overall survival or progression-free survival in a phase 3 study…

Biogen will complete its FDA-mandated phase 4 Aduhelm study in four years — less than half the time the agency allotted when it granted accelerated approved for the controversial antiamyloid…